| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| H1000 |
Prenatal care, at-risk assessment |
278,514 |
207,577 |
$15.39M |
| 59410 |
|
2,749 |
2,463 |
$2.08M |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
19,200 |
17,129 |
$1.51M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
40,378 |
35,731 |
$1.41M |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
26,454 |
25,557 |
$1.22M |
| 76830 |
Ultrasound, transvaginal |
11,572 |
10,446 |
$1.10M |
| 59430 |
|
9,720 |
8,958 |
$1.08M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
13,676 |
11,607 |
$746K |
| 59515 |
|
668 |
595 |
$722K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
7,161 |
6,717 |
$684K |
| 76818 |
|
6,020 |
3,669 |
$593K |
| H1001 |
Prenatal care, at-risk enhanced service; antepartum management |
4,514 |
4,246 |
$552K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
3,099 |
2,929 |
$523K |
| 76813 |
|
3,781 |
3,550 |
$321K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
5,822 |
5,059 |
$309K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
7,775 |
7,119 |
$241K |
| 59025 |
Fetal non-stress test |
9,130 |
7,055 |
$216K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
1,452 |
1,348 |
$185K |
| 76801 |
|
1,638 |
1,475 |
$150K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,557 |
1,474 |
$142K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
4,158 |
2,990 |
$140K |
| 59409 |
Vaginal delivery only (with or without episiotomy and/or forceps) |
160 |
148 |
$139K |
| 87481 |
|
4,552 |
3,469 |
$127K |
| 58300 |
|
241 |
232 |
$124K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
6,809 |
6,627 |
$118K |
| 87511 |
|
4,110 |
3,916 |
$113K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
2,144 |
1,906 |
$110K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,943 |
2,657 |
$89K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
24,599 |
23,729 |
$80K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
937 |
836 |
$77K |
| 88141 |
|
1,612 |
1,520 |
$77K |
| 58558 |
|
113 |
105 |
$60K |
| 99403 |
|
1,146 |
1,033 |
$58K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
12,880 |
12,476 |
$50K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
776 |
710 |
$44K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
999 |
847 |
$39K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
8,344 |
7,855 |
$39K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
805 |
668 |
$35K |
| 99385 |
|
349 |
340 |
$35K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,057 |
985 |
$30K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,915 |
1,721 |
$25K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
1,815 |
1,533 |
$23K |
| 81025 |
|
8,293 |
7,514 |
$22K |
| J7298 |
Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg |
38 |
38 |
$20K |
| 93922 |
|
190 |
186 |
$19K |
| 76820 |
|
1,819 |
955 |
$17K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
4,169 |
3,895 |
$15K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
739 |
641 |
$13K |
| 87625 |
|
364 |
357 |
$12K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
89 |
65 |
$12K |
| 81513 |
|
588 |
484 |
$10K |
| 99205 |
Prolong outpt/office vis |
99 |
95 |
$9K |
| 76857 |
|
234 |
210 |
$7K |
| 99215 |
Prolong outpt/office vis |
72 |
71 |
$7K |
| 59899 |
|
18 |
13 |
$5K |
| 95921 |
|
189 |
177 |
$5K |
| 93975 |
|
28 |
16 |
$3K |
| 11981 |
|
30 |
25 |
$2K |
| 76825 |
|
32 |
17 |
$2K |
| 87529 |
|
83 |
54 |
$2K |
| 54150 |
|
24 |
24 |
$2K |
| 96127 |
|
675 |
605 |
$2K |
| 76821 |
|
40 |
13 |
$2K |
| 81002 |
|
3,924 |
3,188 |
$2K |
| 99306 |
Prolong nursin fac eval 15m |
19 |
16 |
$2K |
| 87210 |
|
1,508 |
1,393 |
$1K |
| 36415 |
Collection of venous blood by venipuncture |
497 |
445 |
$1K |
| 81003 |
|
823 |
647 |
$969.30 |
| 59514 |
|
16 |
12 |
$784.48 |
| 76827 |
|
30 |
15 |
$551.12 |
| 85018 |
|
1,052 |
975 |
$477.70 |
| 88342 |
|
15 |
13 |
$260.51 |
| 87563 |
|
180 |
146 |
$139.32 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
69 |
68 |
$120.03 |
| 80305 |
|
44 |
27 |
$108.36 |
| 87220 |
|
13 |
13 |
$63.48 |
| 82947 |
|
97 |
79 |
$30.57 |
| 82950 |
|
108 |
107 |
$29.16 |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
1,078 |
853 |
$25.29 |
| 90686 |
|
30 |
27 |
$10.00 |
| 99459 |
|
35 |
27 |
$7.96 |
| 90715 |
|
25 |
25 |
$0.00 |
| G0476 |
Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test |
69 |
55 |
$0.00 |
| G0101 |
Cervical or vaginal cancer screening; pelvic and clinical breast examination |
12 |
12 |
$0.00 |
| 99000 |
|
32 |
27 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
51 |
43 |
$0.00 |
| Q0111 |
Wet mounts, including preparations of vaginal, cervical or skin specimens |
15 |
15 |
$0.00 |
| Q0112 |
All potassium hydroxide (koh) preparations |
13 |
13 |
$0.00 |